Global HPV Testing and PAP Test Market is set to grow at a CAGR of 12-15 % by 2027 - Rising number of HPV Cases Globally has led to a Rapid Growth in the number of Cervical Cancers

Cervical cancer is a malignant tumor which starts in the cells of the cervix, the lowermost part of the uterus. Cervical cancer begins when the cells on its surface transform into precancerous cells. If not destroyed or removed early, these abnormal cells may turn into cancer cells and spread in the cervix and surrounding organs. Cervical cancer screening involves the HPV and PAP tests, which can detect HPV infection or pre-cancerous lesions at an early stage and if treatment is offered at the correct time then the cancer can be prevented.

Slowdown in the Global HPV and PAP Test Market Due to Covid-19 Pandemic

The Covid-19 pandemic had impacted all the segments of healthcare in many ways. During the Covid pandemic, due to strict social-distancing norms in hospitals and clinics, there was a slowdown in many diagnostic examinations and surgical procedures. The slowdown in the cancer screening services due to a lack of healthcare staff and interference in the supply chain of testing kits across the world had led to a severe impact on the worldwide market during the Covid pandemic.

However, in April 2020 amidst the pandemic when all non-emergence procedures stopped, in Sweden HPV sampling kits were distributed among the eligible group of women across the country.

Recent Technological Developments and Advancements in the HPV Testing and PAP Test Market

The rising demand for the development of advanced screening tests for the early detection of cervical and vaginal cancers is projected to drive the growth of the HPV testing and PAP test market. The surge in the number of screening campaigns arranged by the government and non-government companies is another major factor driving the growth of the HPV testing and PAP test market globally.

"When everything came to a halt, we had to think of something different. The expectation was that many women will be prevented from developing cervical cancer and that we will grow faster on the path to reaching the WHO target of elimination of cervical cancer with the help of these kits."-Cancer Specialist, Research-Led Medical University, Sweden

Growing Cases of Cervical Cancer Boosts the Global Growth of the HPV Testing and PAP Test Market

An increasing cases of cervical cancers, growing aging population and the development of innovative technological screening tests are the major factors driving the growth of the global market. Public awareness campaigns initiated by the government organizations, enhancing health insurance coverage and favourable reimbursement policies are some of the other factors triggering the demand for HPV Testing and PAP Test market globally.

Upcoming Market Challenges: HPV Testing and PAP Test Market

The adoption of revised regulatory guidelines for cervical cancer screening, the availability of HPV vaccinations and the higher costs of screening tests in the developing countries may impact the growth of the global HPV Testing and PAP Test market in the coming few years.

North America Holds the Largest Market Share in HPV Testing and PAP Test Market

North America holds the largest market share in the global HPV Testing and PAP Test market. This can be mainly attributed due to an increasing number of cervical cancers, favourable reimbursement policies, the presence of leading market players and the fully developed healthcare ecosystem in this region.

However, the APAC region is set to grow with a highest CAGR during the forecast period. Major factors such as technological innovations, free screening and awareness programs and initiatives adopted by all the public and private organizations are some of the major factors driving the growth of the Asia-Pacific market.

Competitive Landscape Analysis: HPV Testing and PAP Test Market

Some of the leading and well-established players operating in the global HPV Testing and PAP test market are listed below: -
• Abbott Laboratories
• F. Hoffmann-La Roche AG
• Becton, Dickinson and Company
• Quest Diagnostics
• Hologic
• Femasys
• Arbor Vita Corporation
• Seegene
• Thermo Fischer Scientific

The global HPV Testing and PAP test market is an emerging market and is expected to gain further momentum in the upcoming years due to a rise in awareness for early diagnosis of cervical cancer, investment in R&D to introduce several advanced screening tests, and aggressive organic and inorganic growth strategies followed by the top market players.

Get Detailed Insights on HPV Testing & PAP Test Market with a Sample Report @ https://meditechinsights.com/hpv-testing-and-pap-test-market/

Ruta Halde
Associate, Medi-Tech Insights
121/7E Avenue Franklin Roosevelt,
1050 Brussels, Belgium
+32 498 86 80 79
info@meditechinsights.com
https://meditechinsights.com/

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services.

This release was published on openPR.